the synthesis of more specific cytochrome p-450 enzyme inhibitors and of mitotane analogues with more limited toxicity may ultimately provide more effective tools in the pharmacologic management of cushing 's syndrome .
C0026256
mitotane
C0010481
cushing 's syndrome